Cargando…
Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model
This Phase II study evaluated analgesia, abuse liability, and cognitive performance of hydromorphone and oral delta-9-tetrahydrocannabinol (THC; dronabinol) using a within-subject, double-blind, randomized, placebo-controlled, human laboratory trial. Healthy adults (N = 29) with no history of drug u...
Autores principales: | Dunn, Kelly E., Bergeria, Cecilia L., Huhn, Andrew S., Speed, Traci J., Mun, Chung Jung, Vandrey, Ryan, Campbell, Claudia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055479/ https://www.ncbi.nlm.nih.gov/pubmed/33879842 http://dx.doi.org/10.1038/s41386-021-01007-4 |
Ejemplares similares
-
Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
por: Campbell, Claudia M., et al.
Publicado: (2023) -
Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
por: Durgin, Caitlyn J., et al.
Publicado: (2023) -
Evaluation of Stigma Related to Perceived Risk for Coronavirus-19 Transmission Relative to the Other Stigmatized Conditions Opioid Use and Depression
por: Okobi, Sandra, et al.
Publicado: (2022) -
A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans
por: Dunn, Kelly E., et al.
Publicado: (2019) -
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
por: Parikh, Neha, et al.
Publicado: (2016)